ATE496130T1 - Verfahren zur identifizierung von modulatoren eines g-protein-gekoppelten rezeptors - Google Patents
Verfahren zur identifizierung von modulatoren eines g-protein-gekoppelten rezeptorsInfo
- Publication number
- ATE496130T1 ATE496130T1 AT04818967T AT04818967T ATE496130T1 AT E496130 T1 ATE496130 T1 AT E496130T1 AT 04818967 T AT04818967 T AT 04818967T AT 04818967 T AT04818967 T AT 04818967T AT E496130 T1 ATE496130 T1 AT E496130T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- dna
- coupled receptor
- function
- identifying
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Psychiatry (AREA)
- Pathology (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003389624 | 2003-11-19 | ||
| JP2004130371 | 2004-04-26 | ||
| JP2004304780 | 2004-10-19 | ||
| PCT/JP2004/017239 WO2005049833A1 (ja) | 2003-11-19 | 2004-11-19 | G蛋白質共役型受容体をコードする遺伝子およびその遺伝子産物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE496130T1 true ATE496130T1 (de) | 2011-02-15 |
Family
ID=34623571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04818967T ATE496130T1 (de) | 2003-11-19 | 2004-11-19 | Verfahren zur identifizierung von modulatoren eines g-protein-gekoppelten rezeptors |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1693456B1 (de) |
| JP (1) | JP4638354B2 (de) |
| AT (1) | ATE496130T1 (de) |
| DE (1) | DE602004031148D1 (de) |
| DK (1) | DK1693456T3 (de) |
| WO (1) | WO2005049833A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7527937B2 (en) | 2003-11-19 | 2009-05-05 | Daiichi Sankyo Company, Limited | Assay employing a g-protein coupled receptor that is activated by CCK-8S |
| JPWO2006118289A1 (ja) * | 2005-05-02 | 2008-12-18 | 第一三共株式会社 | 抗うつ作用を有する化合物の同定方法 |
| JPWO2008053962A1 (ja) * | 2006-11-02 | 2010-02-25 | 第一三共株式会社 | 抗不安作用を有する化合物の同定方法 |
| JP4691571B2 (ja) | 2008-03-04 | 2011-06-01 | 株式会社マルハニチロ食品 | 摂食調節剤 |
| JP2010235492A (ja) * | 2009-03-31 | 2010-10-21 | Sekisui Chem Co Ltd | シャペロニン−目的タンパク質複合体及びその製造方法 |
| US10364350B2 (en) | 2009-04-20 | 2019-07-30 | Agency For Science, Technology And Research | Vesicular system and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4001976B2 (ja) * | 1997-05-23 | 2007-10-31 | オンコセラピー・サイエンス株式会社 | ヒトbai遺伝子及びその利用 |
| WO2002061087A2 (en) * | 2000-12-19 | 2002-08-08 | Lifespan Biosciences, Inc. | Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides |
| JP2003284573A (ja) * | 2001-06-18 | 2003-10-07 | National Institute Of Advanced Industrial & Technology | グアノシン三リン酸結合タンパク質共役型の受容体 |
| US20030143668A1 (en) * | 2001-06-18 | 2003-07-31 | National Institute Of Advanced Industrial | Guanosine triphosphate-binding protein coupled receptors |
-
2004
- 2004-11-19 DE DE602004031148T patent/DE602004031148D1/de not_active Expired - Lifetime
- 2004-11-19 AT AT04818967T patent/ATE496130T1/de not_active IP Right Cessation
- 2004-11-19 EP EP04818967A patent/EP1693456B1/de not_active Expired - Lifetime
- 2004-11-19 JP JP2005515653A patent/JP4638354B2/ja not_active Expired - Fee Related
- 2004-11-19 DK DK04818967.4T patent/DK1693456T3/da active
- 2004-11-19 WO PCT/JP2004/017239 patent/WO2005049833A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005049833A1 (ja) | 2005-06-02 |
| EP1693456B1 (de) | 2011-01-19 |
| DK1693456T3 (da) | 2011-03-21 |
| JPWO2005049833A1 (ja) | 2007-06-07 |
| JP4638354B2 (ja) | 2011-02-23 |
| EP1693456A4 (de) | 2007-07-11 |
| EP1693456A1 (de) | 2006-08-23 |
| DE602004031148D1 (de) | 2011-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9912437A (pt) | ácidos nucléicos codificando um receptor ligado à proteìna g envolvido na transdução sensória | |
| NO2010021I1 (no) | Denosumab | |
| ATE512987T1 (de) | Verfahren zur in-vitro-diagnose von alzheimer- krankheit mit einem monoklonalen antikörper | |
| ATE421697T1 (de) | Verfahren zur identifizierung von verbindungen, die transmembran-proteine beeinflussen | |
| EP2311955A3 (de) | Osteoprotegerin bindende Proteine und deren Rezeptoren | |
| CA2316280A1 (en) | Novel g protein-coupled receptor | |
| BR9912545A (pt) | ácidos nucleicos codificando um receptorcopulado a proteìna g envolvido em transduçãosensorial | |
| EP1589106A4 (de) | Adiponektin-rezeptor und dafür kodierendes gen | |
| ATE393237T1 (de) | Mittel und verfahren zur in-vitro-bestimmung von camp | |
| RU2004125585A (ru) | Новые флуоресцирующие белки aequorea coerulscens и способы их применения | |
| BRPI0616712B8 (pt) | método para amidar polipeptídeos com terminais c de aminoácido básicos por meio de endoproteases específicas | |
| DE602004031148D1 (de) | Verfahren zur identifizierung von modulatoren eines g-protein-gekoppelten rezeptors | |
| ATE496304T1 (de) | Ligand für den formylpeptidrezeptorähnlichen-2 (fprl2) g protein gekoppelten rezeptor | |
| ATE474922T1 (de) | Fluoreszenzproteine aus copepoda-spezies und verfahren zur verwendung davon | |
| DE60219645D1 (de) | Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft | |
| EP1565559A4 (de) | Fluoreszenzproteine und chromoproteine aus nicht-aequorea-hydrozoa-spezies sowie verfahren zur verwendung davon | |
| ATE331032T1 (de) | Glutamine: fructose-6-phosphat amidotransferase (gfat), ihre herstellung und verwendung | |
| US20220073908A1 (en) | Methods of producing high diversity peptide libraries and promoting protein folding | |
| ATE462721T1 (de) | Breit einsetzbares verfahren zur identifizierung von modulatoren von g-protein gekoppelten rezeptoren | |
| WO2003057827A3 (en) | Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes | |
| WO2004074446A3 (en) | Parkin interacting polypeptides and methods of use | |
| DE60223937D1 (de) | Nukleinsäuren kodierend miteinander verbundene chromo/fluoreszenzdomänen und verfahren zu ihrer verwendung | |
| Raftery et al. | Structural and functional aspects of the nicotinic acetylcholine receptor | |
| Hinson | Development of tools for single molecule peptide fluorosequencing | |
| ATE445159T1 (de) | Neues screening-verfahren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |